Table 3.
The number and percentage of participants with abnormal measures at baseline and follow-up and the number and percentage with normalized measures at follow-up of those with abnormal baseline measures
Measure | Abnormal at Baseline N (%) |
Normalized measure at follow-up of those with abnormal measure at baseline N (%) |
Abnormal at Follow-up | p value* |
---|---|---|---|---|
Waist Circumferencea | 133 (92.4%) | 10 (7.5%) | 127 (88.2%) | p = 0.180 |
Blood Pressureb | ||||
Systolic blood pressure | 64 (44.4%) | 33 (51.6%) | 55 (38.2%) | p = 0.289 |
Diastolic blood pressure | 20 (13.9%) | 18 (90.0%) | 15 (10.4%) | p = 0.473 |
Lipid Levelsc | ||||
Total cholesterol | 67 (46.5%) | 16 (23.9%) | 65 (45.1%) | p = 0.856 |
High-density lipoprotein | 48 (33.3%) | 22 (45.8%) | 38 (26.4%) | p = 0.121 |
Low-density lipoprotein | 50 (34.7%) | 13 (26.0%) | 54 (37.5%) | p = 0.585 |
Triglycerides | 37 (25.7%) | 18 (48.6%) | 39 (27.1%) | p = 0.871 |
Fasting Glucosed | 7 (4.9%) | 6 ((85.7%) | 3 (2.1%) | p = 0.289 |
Presence of 3 or more components of the metabolic syndromee | 44 (30.6%) | 22 (50.0%) | 39 (27.1%) | p = 0.522 |
*p-values refer to McNemar tests
aWaist circumference ≥ 90th percentile for age and sex was defined as abnormal [14]
bHypertension was defined as SBP or DBP ≥ 90th percentile for age, sex, and height [14]
cAbnormal lipid levels were defined as: TC ≥ 160 mg/dL; HDL ≤ 40 mg/dL; LDL ≥ 110 mg/dL; and TG ≥ 110 mg/dL for those 12 yrs. and older or ≥ 90th percentile for age and sex [14]
dAbnormally high fasting glucose level was defined as ≥110 mg/dL [14]
eDefined as presence of 3 or more of the following: increased waist circumference, systolic or diastolic hypertension, a high TG level, a low HDL level, or elevated fasting glucose concentration